Search


Current filters:



Clear current filters  or Add more filters

View Option



Results 1-10 of 20 (Search time: 0.005 seconds).

  LDL cholesterol estimation in patients with the metabolic syndrome (Journal article)

  Urine of patients with nephrotic syndrome contains the plasma type of PAF-acetylhydrolase associated with lipoproteins (Journal article)

  The changes in plasma retinol-binding protein 4 levels are associated with those of the apolipoprotein B-containing lipoproteins during dietary and drug treatment (Journal article)

  The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome (Journal article)

  The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol (Journal article)

  High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemia (Journal article)

  Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels (Journal article)

  Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients(1) (Journal article)

  Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-gamma activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A (Journal article)

  Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles (Journal article)